ATHE
Alterity Therapeutics Ltd
Supply chain · Ownership · Earnings
Alterity Therapeutics Ltd has 6 disclosed suppliers and 0 disclosed customers in SEC filings.
6 disclosed: JonesTrading Institutional Services LLC, PricewaterhouseCoopers, The Bank of New York Mellon (BNYM) and 3 more; 1 is a partnership or agreement.
No disclosed customers.
No changes in the last 30 days.
Sources
sec edgar · verbatim disclosure“Subject to the terms and conditions of the sales agreement, JonesTrading agreed to use its commercially reasonable efforts to sell the ADSs from time to time as agent, based upon our instructions.”
“PricewaterhouseCoopers was appointed as the Group's principal independent registered public accounting firm on November 30, 2006.”
“For the year ended June 30, 2026, we paid BNYM a total of U.S.$35,611 (comprised of payments for the distribution and printing of meeting material and proxy vote tabulation).”
“Since 2009, our chemistry program has been undertaken within laboratories leased from The University of Melbourne's Bio21 Molecular Science and Biotechnology Institute, which is a multidisciplinary research center that specializes in medical, agricultural and environmental biotechnology.”
“In the year ended June 30, 2026, we recorded A$3.6 million in other income with respect to funds we expect to receive in relation to the 2026 financial year under the research and development tax incentive scheme.”
“The study was conducted in collaboration with Vanderbilt University Medical Center in the U.S. under the direction of Daniel Claassen, MD, Professor of Neurology and Principal Investigator.”
Alterity Therapeutics Ltd
Supply chain · Ownership · Earnings
Nasdaq · Manufacturing
High 3.50 9:30 am · Low 3.50 9:30 am ET
ATHE (Alterity Therapeutics Ltd) has 6 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Distance from centre = disclosure strength · Extended: 2nd-degree ties, single companies only